Subgroup analysis of only fit patients without co-morbidities showed a strong trend towards improving survival with NACT and surgery, ultimately concluding that the benefit of NACT was reproducible only for fit and healthy patients.
← all excerpts
Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
1
—
—